Search For "sii"
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 3 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More
Reports that Centre rejected SII, Bharat Biotech's emergency use authorisa
Updated : 5 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
Read More
Baijal reviews preparedness for COVID-19 vaccination in Delhi
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): Delhi Lieutenant Governor Anil Baijal on Monday chaired a meeting with Principal Secretary (Health) and Directorate General of Health Services (DGHS) and additional director of Serum Institute of India (SII) to review preparedness for COVID-19 vaccination
Read More
SII CEO thanks PM Modi for support after seeking emergency authorisation o
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the central government for the support.
Read More
Serum Institute of India seeks emergency use authorisation for its COVID-1
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
Read More
Covishield safe, immunogenic; incident with Chennai volunteer no way induc
Updated : 5 years, 3 months ago IST
New Delhi [India], December 1 (ANI): Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by the vaccine as "requisite regulatory and ethical processes and guideline"
Read More
No correlation of vaccine trial with Chennai volunteer's side effect claim
Updated : 5 years, 3 months ago IST
New Delhi [India], November 29 (ANI): After a Chennai-based man claimed that he suffered neurological and psychological side effects after taking a shot of COVID-19 vaccine candidate Covishield during the human trial, being conducted by Serum Institute of India's (SII), the Pune-based com
Read More
Amazed at how much PM Modi knew, says SII's Adar Poonawalla
Updated : 5 years, 3 months ago IST
Pune (Maharashtra) [India], November 28 (ANI): Hours after Prime Minister Narendra Modi visited Pune-based Serum Institute of India (SII), its Chief Executive Officer Adar Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and vaccine production.
Read More
Centre may purchase 300-400 million Covishield doses by July 2021: Adar Po
Updated : 5 years, 3 months ago IST
New Delhi [India], November 28 (ANI): After Prime Minister Narendra Modi visited the company's pandemic level facility in Pune, Serum Institute of India's (SII), Chief Executive Officer (CEO) Adar Poonawalla on Saturday said that indications suggest that the central government may purchase 3
Read More
Preparations underway at Serum Institute of India ahead of PM Modi's visit
Updated : 5 years, 4 months ago IST
Pune (Maharashtra) [India], November 27 (ANI): Preparations are underway at Serum Institute of India (SII) where Prime Minister Narendra Modi is expected to visit on November 28 to review the COVID-19 vaccine production and its distribution mechanisms.
Read More
Will have to wait for final words in scientific journal: CSIR chief on Cov
Updated : 5 years, 4 months ago IST
New Delhi [India], November 25 (ANI): A day after Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla asserted that its "soon to be widely available COVID-19 vaccine will offer protection up to 90 per cent in one type of dosage regime", Council of Scientific and Industrial
Read More
Serum Institute of India CEO expresses delight at Covishield vaccine effic
Updated : 5 years, 4 months ago IST
New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is delighted to hear that Covidshield, soon to be widely available COVID-19 vaccine, will offer protection up to 90 per cent in one dosage regime and 62 per cent in another.
Read More